Optical freedom
IN THE PICTURE
Acuvue Oasis Max
As our lives change, so do the demands on our eyes, particularly in our digitally-dependent world, which can impact our comfort throughout the day. Moreover, blue-violet light is all around us, all day, indoor and out, impacting on visual clarity.*
ACUVUE® OASYS MAX 1-Day has an unprecedented combination of two innovative technologies**:
TearStable™ Technology and OptiBlue™ Light Filter to help deliver MAX comfort and MAX clarity.***
ACUVUE® OASYS MAX 1-Day provides all day clear and comfortable vision+3, in all lighting conditions+3.
* JJV Data on File 2022. Blue-Violet Filter Utilized in ACUVUE® OASYS MAX 1-Day contact lenses.
** JJV Data on File, 2022. TearStable Technology Definition.
*** JJV Data on File 2022. CSM Subjective Responses ACUVUE® OASYS MAX 1-Day Contact Lenses- Retrospective Meta-analysis.
Contact lenses
KiDS
MySight
Kids lead active, jam-packed lives. But whether they’re playing pretend, riding bikes with their friends, or learning new things at school, myopia (nearsightedness) can make it harder for them to engage in the activities they love. And as they grow, their prescription may get stronger too. Fortunately, your age-appropriate children may benefit from an innovative technology to help slow down the progression of their myopia*: MiSight® 1 day contact lenses from CooperVision. MiSight® 1 day contact lenses with ActivControl® Technology not only correct nearsightedness – they’re also the first soft contact lenses proven to slow the progression of myopia in children in children aged 8-12 at initiation of treatment.* When wearing MiSight® 1 day contact lenses, your age-appropriate child can experience clear vision, freedom from glasses and continue to enjoy the activities they love.*+**
References: *Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019;96(8):556–567. **Sulley A, et al. Wearer experience and subjective responses wth dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. Poster presented at AAO 2019, San Francisco, Calif. Chamberlain P, et al, Further comparison of myopia progression in new and established myopia control treatment (MiSight® 1 day) groups. Presentation at BCLA 2019, Manchester, England.
References:
*Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019;96(8):556–567.
**Sulley A, et al. Wearer experience and subjective responses wth dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. Poster presented at AAO 2019, San Francisco, Calif. Chamberlain P, et al, Further comparison of myopia progression in new and established myopia control treatment (MiSight® 1 day) groups. Presentation at BCLA 2019, Manchester, England.
Mallon + taub London marylebone
OUR CONTACT LENS PARTNERS
Why choose us
Thorough eye examination including extensive health checking
Highly qualified and experienced optometrists
Contact lenses to suit all needs and prescriptions
Ongoing commitment to aftercare